Archive · 25 Sep 2026
PB Fintech Shares Plunge as Insurance Commission Reforms Spark Fears
PB Fintech, the company that owns Policybazaar, saw its share price fall sharply.
Different reports said the stock dropped either 28% to Rs 1,360.80 or 34% to Rs 1,207.20.
The fall followed proposed insurance rules from IRDAI.
These rules could reduce the money companies earn from selling some insurance policies.
Health, motor and credit-life insurance could be affected the most.
Jefferies estimated that a 10% cut in new-business commissions could reduce PB Fintech’s earnings by 10-12%.
PB Fintech may respond by hiring fewer people and spending less on marketing.
Some analysts still expect the stock to rise, while others are concerned about the company’s business model.
PB Fintech shares fell 28% to Rs 1,360.80 in one report and 34% to Rs 1,207.20 on September 24 in another.
The proposed IRDAI reforms could sharply reduce commissions for health, motor and credit-life insurance products.
Jefferies estimated a 10% reduction in new-business commissions could lower PB Fintech’s earnings by 10-12%.
The company may slow hiring, reduce marketing expenses and preserve cash to manage the potential impact.
Brokerages remained divided, with positive ratings from Jefferies, Bernstein, Macquarie and Ambit Capital, while Nomura was Neutral and Emkay warned of business-model risks.
- Who
- PB Fintech, the parent of Policybazaar; the Insurance Regulatory and Development Authority of India; retail shareholders; and brokerage firms including Jefferies, Emkay Global, Bernstein, Macquarie, Nomura, Ambit Capital and IIFL Securities.
- What
- PB Fintech shares dropped sharply after proposed insurance-distribution reforms raised concerns about lower commissions, earnings and the company’s business model.
- When
- The sharpest single-day fall was reported on September 24, while shareholding data cited in another report was as of June 30; the articles do not consistently specify the year.
- Where
- In stock-market trading; the specific exchange is not identified in the articles.
- Why
- Investors reacted to proposed changes that could reduce insurance commissions and expenses, particularly in health, motor and credit-life insurance.
Regulatory-Risk View
Brokerage-Support View
Effect on earnings
Regulatory-Risk View
Jefferies estimated that a 10% reduction in new-business commissions could reduce earnings by 10-12%, while Emkay said the business model could come under question.
Brokerage-Support View
Jefferies retained a Buy rating and said its revised Rs 1,540 target implied about 28% upside from Rs 1,207.20.
Insurance segment impact
Regulatory-Risk View
Jefferies said non-life insurance could face greater pressure, with PB Fintech indicating that non-life business value could fall to 33-40% of its original level if proposed health and motor cuts take effect.
Brokerage-Support View
Jefferies said the impact on life insurance could be more limited because of higher renewal commissions in term insurance.
Stock outlook
Regulatory-Risk View
Nomura recommended Neutral with a Rs 1,590 target, and Emkay and IIFL Securities highlighted risks from steep proposed commission reductions.
Brokerage-Support View
Bernstein and Macquarie rated the stock Outperform, Ambit Capital rated it Buy, and Jefferies maintained Buy despite lowering its target.
- Company
- PB Fintech is the parent company of Policybazaar.
- Reported share-price declines
- One report cited a 28% fall to Rs 1,360.80; another cited a 34% fall to Rs 1,207.20 on September 24.
- Retail shareholders
- 1,42,294 individual investors held shares worth up to Rs 2 lakh each as of June 30.
- Health commission proposal
- The draft proposes a 5% cap compared with 40% currently, according to IIFL Securities.
- Credit-life commission proposal
- The draft proposes 2% compared with 28% currently.
- Motor commission proposal
- The draft proposes no commission on loan-packaged motor third-party insurance and 5% on own-damage insurance, compared with 16% currently for each category.
- Jefferies estimate
- A 10% reduction in new-business commission rates could result in a 10-12% earnings decline.
- Jefferies target
- Jefferies maintained a Buy rating but cut its target to Rs 1,540 from Rs 2,050.
